SalaryGuide
SalariesCompaniesJobs
AboutPricingBlogFor Employers

Marketing jobs

6 marketing jobs

CareDx, Inc. logo
3 weeks ago

Marketing Director - Anal Cancer

CareDx, Inc.

Waltham, MA (Remote)Full time$192K/yr – $270K/yr
CareDx, Inc. logo
3 weeks ago

Marketing Director - H&N Cancer

CareDx, Inc.

Waltham, MA (Remote)Full time$192K/yr – $270K/yr
CareDx, Inc. logo
2 months ago

Director Marketing CTT

CareDx, Inc.

Brisbane, CA (Hybrid)Full time$250K/yr – $270K/yr
CareDx, Inc. logo
5 months ago

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (On-site)Full time$94K/yr – $125K/yr
CareDx, Inc. logo
6 months ago

Corporate Communications Summer Intern 2026

CareDx, Inc.

Brisbane, CA (On-site)Volunteer$20/hr – $25/hr
CareDx, Inc. logo
6 months ago

Senior Manager, Commercial Technology & CRM

CareDx, Inc.

Brisbane, CA (On-site)Full time$135K/yr – $175K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

6 jobs
CareDx, Inc. logo

Marketing Director - Anal Cancer

CareDx, Inc.

Waltham, MA (Remote)

$192K/yr - $270K/yrIn-houseFull-timeSenior level8+ years exp.
3 weeks ago
CareDx, Inc. logo

Marketing Director - H&N Cancer

CareDx, Inc.

Waltham, MA (Remote)

$192K/yr - $270K/yrIn-houseFull-timeSenior level8+ years exp.
3 weeks ago
CareDx, Inc. logo

Director Marketing CTT

CareDx, Inc.

Brisbane, CA (Hybrid)

$250K/yr - $270K/yrIn-houseFull-timeSenior level
2 months ago
CareDx, Inc. logo

Brand Marketing Manager

CareDx, Inc.

Brisbane, CA (On-site)

$94K/yr - $125K/yrIn-houseFull-timeMid level3+ years exp.
5 months ago
CareDx, Inc. logo

Corporate Communications Summer Intern 2026

CareDx, Inc.

Brisbane, CA (On-site)

$20/hr - $25/hrIn-houseVolunteerIntern/new grad
6 months ago
CareDx, Inc. logo

Senior Manager, Commercial Technology & CRM

CareDx, Inc.

Brisbane, CA (On-site)

$135K/yr - $175K/yrIn-houseFull-timeSenior level
6 months ago
CareDx, Inc. logo
CareDx, Inc.

Marketing Director - Anal Cancer

Waltham, MA (Remote)

$192K/yr – $270K/yrSenior Level8+ years expFull time

Posted 3 weeks ago

  • Job
  • Company
  • Salaries
  • People
  • Funding
  • Audience
  • News
  • Links

Job Summary

Own and drive the end-to-end Specialty Oncology marketing strategy, from multi-year brand planning to market development and cross-functional execution, with a focus on NavDx adoption, evidence translation, and channel-optimized promotion.

  • Own the annual marketing plan and multi-year roadmap, aligning with growth objectives and patient journey insights.
  • Lead market development, segmentation, and cross-functional collaboration to accelerate adoption and utilization.
  • Translate complex data into differentiated messaging, field tools, and compliant marketing materials that drive adoption and outcomes.

Job Description

Responsibilities

  • Brand Strategy and Annual Planning : Develop and execute an integrated, insight-driven marketing strategy for the specialty oncology franchise. Own the annual marketing plan and multi-year brand roadmap, aligned with Specialty Oncology growth objectives, evolving evidence, market access priorities, customer needs, and patient journey.
  • Market Development and Adoption : Design initiatives that expand appropriate NavDx adoption across priority HPV-driven cancers and care settings. Identify barriers to testing, segment customers by opportunity and readiness, and develop strategies that increase ordering-provider reach, reactivate lapsed users, deepen utilization, and support integration into patient-management workflows.
  • Commercial Focus and Indication Expansion : Translate franchise priorities into focused commercial plans for established and emerging use cases. Support continued growth in anal cancer as evidence, market readiness, and organizational priorities evolve.
  • Customer and Market Insights : Use quantitative and qualitative insights, including sales performance, ordering behavior, market research, competitive intelligence, field feedback, KOL input, and customer journey analysis, to identify opportunities, sharpen segmentation, and guide investment decisions.
  • Positioning, Messaging, and Promotional Execution : Develop differentiated positioning and compelling messaging for healthcare professionals, care teams, KOLs, patients, and other relevant stakeholders. Lead the creation and deployment of field tools, sales aids, digital campaigns, speaker materials, email content, website content, objection handlers, and competitive resources that are clinically grounded and action oriented.
  • Clinical Evidence Translation : Partner with Medical Affairs and Clinical Development to translate complex clinical and scientific evidence into clear, compliant, and differentiated marketing strategies. Connect evidence milestones to customer education, adoption barriers, market development, and broader commercial opportunities.
  • Field Enablement and Sales Partnership : Collaborate closely with Sales and Sales Training to equip customer-facing teams with clear strategies, effective tools, and consistent messaging. Establish feedback loops that capture field insight, inform rapid-response materials, and improve execution in priority accounts and territories.
  • Omnichannel and Digital Marketing : In collaboration with the digital marketing center of excellence, develop coordinated personal and non-personal promotion that reaches customers with relevant content at the right point in their adoption journey. Use engagement data and customer behavior to refine channel mix, content sequencing, and campaign effectiveness.
  • Performance Measurement and Resource Allocation : Define KPIs and dashboards that connect marketing activity to business outcomes, including awareness, engagement, ordering-provider growth, customer activation or reactivation, utilization, and campaign effectiveness. Evaluate ROI, optimize spend, and redirect resources toward the highest-impact opportunities.
  • Cross-Functional Leadership and Agency Management : Lead through influence across Marketing, Sales, Medical Affairs, Clinical, Market Access, Digital, Product, Compliance, and Operations. Provide agencies and creative partners with clear briefs, strategic context, brand standards, and actionable feedback to ensure high-quality, timely execution.

Requirements

  • Marketing Experience - At least 8-10 years of relevant marketing experience in diagnostics, biotech, pharma, or medical device industries, with a proven track record of leadership and strategic impact. Strong background in developing strategic, data-driven marketing plans for complex diagnostic or therapeutic products. A proven track record of engaging healthcare professionals (HCPs), key opinion leaders (KOLs), and cross-functional teams, translating clinical data into compelling promotional messaging. Applies market insights to inform pipeline strategy and optimize lifecycle planning. Familiarity with market research methodologies and able to lead complex research projects. Experience leading multichannel campaigns, including digital and social media, and navigating the MLR review process in a highly regulated environment is essential. Additionally, this marketer must be comfortable with budget management, agency collaboration, and driving protocol adherence and pull-through.
  • Health Care/Life Sciences – Experience in Oncology disease state and a HCP-facing healthcare environment is strongly preferred—ideally in Specialty Therapeutics, Diagnostics, Genomics, Life Sciences. Familiarity with HIPAA compliance, data privacy regulations, and the MLR review process is essential. Candidates should have a proven ability to translate complex clinical or scientific data into clear, impactful marketing strategies that drive adoption, adherence, and behavior change across both HCP and patient audiences. Backgrounds in Pharmaceuticals, Medical Devices, or Chronic and Rare Disease marketing are also highly relevant, particularly given their similar stakeholder complexity, patient engagement needs, and regulatory demands.
  • Leadership & Cross-Functional Influence – The Specialty Oncology Marketing Director must be a strong peer leader, self-starter, and collaborator that works effectively across Product, Sales, Clinical, Medical Affairs, and Regulatory to ensure promotional content is clinically accurate, compliant, and strategically aligned. The ideal candidate excels at turning strategy into action, driving alignment across stakeholder groups, and executing initiatives that support both revenue growth and improved patient outcomes. Success in this role requires the ability to influence without authority and thrive in a matrixed, mission-driven organization.
  • Education - A Bachelor’s degree is required, with a strong preference for candidates who hold a BA/BS in Life Sciences, Molecular Biology, or Clinical Science, reflecting a solid foundation in healthcare or scientific disciplines relevant to CareDx’s mission. An MBA or other advanced degree is also preferred, demonstrating advanced training in strategic thinking, business acumen, and cross-functional leadership—key attributes for driving impact in a complex, data-driven, and highly regulated healthcare environment.
  • Required Core Competencies – Strategic Agility, Drive for Results, Leadership, Collaboration and Teamwork, Innovative thinking
CareDx, Inc. logo

CareDx, Inc.

2.6 Glassdoor

CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. Our Mission: Create life-changing solutions that enable transplant patients to thrive.Our Vision: A world where every patient receives the transplant they need to live longer, fuller lives. For more information, visit www.caredx.com.

Founded in 1998
Brisbane, California, USA
www.caredx.com
36% recommend to a friend

Salaries

Posted range

$192K/yr – $270K/yr

Taken straight from the job posting.

See all CareDx, Inc. salaries

Marketing Team

Median Career Experience
17 years
Median Tenure
1.7 years
Marketing Roles Posted (Last 30 Days)
2

People

Founders / CEO

John Hanna
John Hanna
Chief Executive Officer
At the company for 2 years 6 months

HR / Recruitment

Gina Wasielewski
Gina Wasielewski
Director, Head of Talent Acquisition
At the company for 1 year 4 months
Tiffany Shih
Tiffany Shih
Sr Mgr, Head of Talent Acquisition
At the company for 2 years 2 months

Marketing Leadership

Julie Garlikov
Julie Garlikov
VP of Global Marketing
At the company for 1 year 9 months
Gina Wasielewski
Gina Wasielewski
Director, Head of Talent Acquisition
At the company for 1 year 4 months
Tiffany Shih
Tiffany Shih
Sr Mgr, Head of Talent Acquisition
At the company for 2 years 2 months
Troy Knapp
Troy Knapp
Senior Director, Head of Talent Acquisition
At the company for 4 years 8 months

Funding

Total Funding
$574.9M
Last Raise
$164M
Post IPO Equity, 5 years ago

Funding History

  • Jan 2021
    Post IPO Equity • $164M
  • Jun 2020
    Post IPO Equity • $117.1M
  • Nov 2018
    Post IPO Equity • $52.8M

Traffic Signals

Monthly Google Ads Budget
$4

Recent News

CDNA: Wells Fargo Raises Price Target to $18, Maintains Equal-We
Dec 15, 2025 • GuruFocus
CareDx price target raised to $18 from $14 at Wells Fargo
Dec 15, 2025 • TipRanks
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound
Dec 14, 2025 • Yahoo Finance UK
Nikko Asset Management Americas Inc. Reduces Position in CareDx, Inc. $CDNA
Dec 14, 2025 • MarketBeat
CareDx Shares Navigate Conflicting Market Signals
Dec 13, 2025 • AD HOC NEWS
There's No Escaping CareDx, Inc's (NASDAQ:CDNA) Muted Revenues Despite A 26% Share Price Rise
Dec 13, 2025 • 富途牛牛
CareDx, Inc. $CDNA Shares Sold by Bellevue Group AG
Dec 13, 2025 • MarketBeat
CareDx (NASDAQ:CDNA) Lowered to "Hold" Rating by Wall Street Zen
Dec 13, 2025 • MarketBeat
CareDx Reforms Get Nod Following $20 Million Investor Class Deal
Dec 10, 2025 • Bloomberg Law News
Next Century Growth Investors LLC Purchases 850,580 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
Ophir Asset Management Pty Ltd Buys 274,625 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
New York State Common Retirement Fund Acquires 64,175 Shares of CareDx, Inc. $CDNA
Dec 10, 2025 • MarketBeat
CareDx, Inc. $CDNA Shares Bought by Hood River Capital Management LLC
Dec 8, 2025 • MarketBeat
CareDx, Inc. $CDNA Shares Sold by Divisadero Street Capital Management LP
Dec 8, 2025 • MarketBeat
Russell Investments Group Ltd. Has $5.06 Million Stock Holdings in CareDx, Inc. $CDNA
Dec 6, 2025 • MarketBeat
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry
Nov 29, 2025 • simplywall.st
Wall Street Analysts Believe CareDx (CDNA) Could Rally 28.02%: Here's is How to Trade
Nov 27, 2025 • Yahoo Finance
CareDx (NASDAQ:CDNA) Upgraded at Zacks Research
Nov 21, 2025 • Defense World
Is CareDx Inc stock trading near support levels - Portfolio Value Summary & AI Based Buy/Sell Signal Reports
Nov 16, 2025 • newser.com
Is CareDx Inc stock trading near support levels - July 2025 Drop Watch & Reliable Price Breakout Alerts
Nov 15, 2025 • newser.com
Trend analysis for CareDx Inc this week - July 2025 Volume & AI Driven Price Forecasts
Nov 15, 2025 • newser.com
What is the fair value estimate for CareDx Inc (1K9) stock in 2025 - July 2025 Momentum & AI Powered Market Trend Analysis
Nov 14, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - 2025 Bull vs Bear & Technical Pattern Based Buy Signals
Nov 14, 2025 • newser.com
Is CareDx Inc stock trading near support levels - 2025 Geopolitical Influence & Risk Controlled Daily Trade Plans
Nov 14, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - July 2025 Analyst Calls & Intraday High Probability Setup Alerts
Nov 13, 2025 • newser.com
Can CareDx Inc (1K9) stock expand revenue streams - Trend Reversal & Expert Verified Stock Movement Alerts
Nov 13, 2025 • newser.com
Why CareDx Inc (1K9) stock remains stable - Weekly Profit Analysis & Long-Term Safe Investment Plans
Nov 13, 2025 • newser.com
Why CareDx Inc (1K9) stock remains stable - Profit Target & Free High Return Stock Watch Alerts
Nov 12, 2025 • newser.com
Trend analysis for CareDx Inc this week - July 2025 Market Mood & Low Drawdown Investment Strategies
Nov 12, 2025 • newser.com
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability
Nov 12, 2025 • simplywall.st
Why CareDx Inc (1K9) stock remains stable - Weekly Gains Report & Free Daily Entry Point Trade Alerts
Nov 12, 2025 • newser.com
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability
Nov 12, 2025 • Sahm
What is the fair value estimate for CareDx Inc (1K9) stock in 2025 - Portfolio Performance Report & Free Accurate Trade Setup Notifications
Nov 12, 2025 • newser.com
Trend analysis for CareDx Inc this week - Market Volume Report & Free Community Consensus Stock Picks
Nov 10, 2025 • newser.com
CareDx to Participate in Upcoming Investor Conferences
Nov 10, 2025 • The Globe and Mail
Will CareDx Inc (1K9) stock keep high P E multiples - July 2025 Short Interest & Fast Entry and Exit Trade Plans
Nov 10, 2025 • newser.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • The Joplin Globe
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Markets Financial Content
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Business Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 7, 2025 • Yahoo Finance
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript
Nov 6, 2025 • Insider Monkey
BTIG Maintains CareDx (CDNA) Buy Recommendation
Nov 6, 2025 • Nasdaq
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
Nov 6, 2025 • Yahoo Finance
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
Nov 6, 2025 • Business Wire
CareDx (CDNA): Profit Driven by $89.4 Million One-Off Gain Raises Earnings Sustainability Questions
Nov 6, 2025 • Sahm
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches
Nov 5, 2025 • MSN
CareDx Inc. Reports Strong Q3 Earnings Growth
Nov 5, 2025 • TipRanks
CareDx (CDNA) Turns Profitable on $89.4M One-Off Gain, Challenging Quality of Earnings Narrative
Nov 5, 2025 • Yahoo Finance
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 5, 2025 • Investing.com Nigeria
CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance By GuruFocus
Nov 5, 2025 • Investing.com Canada
CareDx Reports Strong Q3 2025 Financial Results
Nov 5, 2025 • TipRanks
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 4, 2025 • Investing.com UK
Caredx Inc earnings beat by $0.36, revenue topped estimates
Nov 4, 2025 • Investing.com UK
Transplant diagnostics firm CareDx Q3 revenue beats estimates, helped by new product launches
Nov 4, 2025 • MarketScreener
CareDx Reports Strong Q3 Financial Results
Nov 4, 2025 • TipRanks
CareDx (NASDAQ: CDNA) raises revenue guidance to $372–$376M; lifts EBITDA outlook
Nov 4, 2025 • Stock Titan
CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Nov 4, 2025 • Yahoo Finance
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution
Nov 4, 2025 • Investing.com
CareDx Inc (CDNA) Q3 2025 Earnings Report Preview: What To Expect
Nov 3, 2025 • Yahoo Finance
Transplant expert Dr. Teuteberg joins CareDx as chief medical officer By Investing.com
Oct 27, 2025 • Investing.com Nigeria
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
Oct 27, 2025 • The Joplin Globe
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
Oct 27, 2025 • Business Wire
CareDx, Inc Appoints Jeffrey John Teuteberg as Chief Medical Officer, Effective October 1, 2025
Oct 27, 2025 • MarketScreener
Transplant expert Dr. Teuteberg joins CareDx as chief medical officer
Oct 27, 2025 • Investing.com
CareDx Appoints Suresh Gunasekaran as New Director
Oct 24, 2025 • TipRanks
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Oct 23, 2025 • Yahoo Finance
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
Oct 23, 2025 • Business Wire
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
Oct 22, 2025 • MarketScreener
CareDx appoints UCSF Health CEO Suresh Gunasekaran to board
Oct 22, 2025 • Investing.com
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
Oct 22, 2025 • Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Lelezard
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
Oct 21, 2025 • Yahoo Finance
Is CareDx, Inc (NASDAQ:CDNA) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 15, 2025 • Yahoo
Is CareDx, Inc (NASDAQ:CDNA) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 15, 2025 • Yahoo Finance
Full 3rd Circ. Won't Rethink $45M CareDx False Ad Case
Oct 15, 2025 • Law360
CareDx, Inc. Experiences Revision in Stock Evaluation Amid Challenging Financial Metrics
Oct 15, 2025 • Markets Mojo
Law Profs Say CareDx False Ad Verdict Should Stand
Oct 6, 2025 • Law360
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
Oct 6, 2025 • The Joplin Globe
CareDx unveils new transplant diagnostics at ASHI 2025 meeting
Oct 6, 2025 • Investing.com
CareDx Asks 3rd Circ. To Rethink $45M False Ad Case
Sep 26, 2025 • Law360
BTIG reiterates Buy rating on CareDx stock, sees comeback in 2026
Sep 23, 2025 • Investing.com
Strs Ohio Takes Position in CareDx, Inc. $CDNA
Sep 23, 2025 • MarketBeat
4 Analysts Assess CareDx: What You Need To Know
Sep 23, 2025 • Benzinga
CDNA: BTIG Reiterates Buy Rating with Steady Price Target | CDNA Stock News
Sep 23, 2025 • GuruFocus
CareDx, Inc's (NASDAQ:CDNA) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
Sep 19, 2025 • simplywall.st
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
Sep 16, 2025 • PR Newswire
CareDx, Inc. $CDNA Shares Bought by Acadian Asset Management LLC
Sep 14, 2025 • Defense World
CareDx stock has upside potential beyond CMS decision, BTIG says
Sep 12, 2025 • Investing.com
CareDx management to meet with BTIG
Sep 9, 2025 • thefly.com
CareDx at Wells Fargo Conference: Strategic Growth and Innovation
Sep 5, 2025 • Investing.com
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • Business Wire
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • Markets Financial Content
CareDx Issues Comment Letter on Draft LCD Policy
Sep 2, 2025 • MarketScreener
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential
Aug 26, 2025 • Yahoo Finance
William Blair initiates coverage on CareDx stock with Market Perform rating
Aug 25, 2025 • Investing.com
CareDx initiated with neutral view at William Blair, here's why
Aug 25, 2025 • thefly.com
Do Options Traders Know Something About CareDx Stock We Don't?
Aug 22, 2025 • Yahoo Finance
CareDx Inc. $20.25M Securities Class Action Settlement
Aug 22, 2025 • Claim Depot
CareDx to Participate in Wells Fargo Healthcare Conference
Aug 21, 2025 • Markets Financial Content

Links

www.caredx.comLinkedInX (Twitter)Crunchbase

This role is listed on SalaryGuide for informational purposes. SalaryGuide is not the employer, recruitment agency, or hiring representative for this position. Hiring decisions and the application process are managed by the employer. SalaryGuide will never ask candidates to pay to apply for a job or request bank details or identification documents as part of an application.